Cordycepin Suppresses The Malignant Phenotypes of Colon Cancer Cells through The GSK3ß/ß-catenin/cyclin D1 Signaling Pathway

Document Type : Original Article


1 Department of General Surgery, Zhejiang Greentown Cardiovascular Hospital, Hangzhou, Zhejiang, China

2 Department of Emergency, Zhejiang Greentown Cardiovascular Hospital, Hangzhou, Zhejiang, China

3 Department of Dermatology, The Second People's Hospital of Yuhang District, Hangzhou, Zhejiang, China


Objective: Cordycepin, also known as 3ˊ-deoxyadenosine, is the main bioactive ingredient of Cordyceps militaris and possesses various pharmacological effects. This study was performed to investigate the role of cordycepin in regulating the biological behaviors of colon cancer cells and the potential mechanism behind it.
Materials and Methods: In this experimental study, after treatment of colon cancer cells with different concentrations of cordycepin, inhibition of proliferation was detected by the 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. Colon cancer cell migration and invasion abilities were analyzed by wound healing and Transwell assays. Flow cytometry was performed to detect cell apoptosis. A lung metastasis model in nude mice was utilized to examine the effect of cordycepin on the metastasis of colon cancer cells in vivo. Western blot was used to quantify GSK3β, β-catenin and cyclin D1 expression levels.
Results: Cordycepin inhibited colon cancer cell proliferation, migration and invasion, induced apoptosis in vitro, and inhibited lung metastasis of colon cancer cells in vivo. GSK-3β inhibitor (CHIR99021) treatment abolished the effects of cordycepin on cell viability, migration, invasion and apoptosis. Additionally, cordycepin promoted the expressions of GSK3β, and inhibited β-catenin and cyclin D1 in colon cancer cells, while co-treatment with CHIR99021 reversed the above effects.
Conclusion: Cordycepin suppresses the malignant phenotypes of colon cancer through the GSK3β/β-catenin/cyclin D1 signaling pathway.


  1. Zhang Q, Li S, Bai L, Yu D, Li H, Tong R. Self-delivery janus-prodrug for precise immuno-chemotherapy of colitis-associated colorectal cancer. ACS Appl Mater Interfaces. 2022; 14(1): 297-306.
  2. Chen Y, Zhang F, Du Z, Xie J, Xia L, Hou X, et al. Proteome analysis of chi revealed its role in colon cancer through the apoptosis and ferroptosis pathway. Front Oncol. 2021; 11: 727130.
  3. Wen J, Min X, Shen M, Hua Q, Han Y, Zhao L, et al. ACLY facilitates colon cancer cell metastasis by CTNNB1. J Exp Clin Cancer Res. 2019; 38(1): 401.
  4. Adnan M, Siddiqui AJ, Hamadou WS, Patel M, Ashraf SA, Jamal A, et al. Phytochemistry, bioactivities, pharmacokinetics and toxicity prediction of with its anticancer potential against human lung, breast and colorectal carcinoma cell lines. Molecules. 2021; 26(3): 768.
  5. Reddy MN, Adnan M, Alreshidi MM, Saeed M, Patel M. Evaluation of anticancer, antibacterial and antioxidant properties of a medicinally treasured fern tectaria coadunata with its Phytoconstituents analysis by HR-LCMS. Anticancer Agents Med Chem. 2020; 20(15): 1845-1856.
  6. Adnan M, Siddiqui AJ, Arshad J, Hamadou WS, Awadelkareem AM, Sachidanandan M, et al. Evidence-based medicinal potential and possible role of Selaginella in the prevention of modern chronic diseases: ethnopharmacological and ethnobotanical perspective. Rec Nat Prod. 2021; 15(5): 355.
  7. Jang HJ, Yang KE, Hwang IH, Huh YH, Kim DJ, Yoo HS, et al. Cordycepin inhibits human ovarian cancer by inducing autophagy and apoptosis through Dickkopf-related protein 1/β-catenin signaling. Am J Transl Res. 2019; 11(11): 6890-6906.
  8. Khan MA, Tania M. Cordycepin in anticancer research: Molecular mechanism of therapeutic effects. Curr Med Chem. 2020; 27(6): 983-996.
  9. Tan L, Song X, Ren Y, Wang M, Guo C, Guo D, et al. Anti-inflammatory effects of cordycepin: a review. Phytother Res. 2020.
  10. Ashraf SA, Elkhalifa AEO, Siddiqui AJ, Patel M, Awadelkareem AM, Snoussi M, et al. Cordycepin for health and wellbeing: A potent bioactive metabolite of an entomopathogenic medicinal fungus and its nutraceutical and therapeutic potential. Molecules. 2020; 25(12): 2735.
  11. Li SZ, Ren JW, Fei J, Zhang XD, Du RL. Cordycepin induces Bax‑dependent apoptosis in colorectal cancer cells. Mol Med Rep. 2019; 19(2): 901-908.
  12. Patel M, Sachidanandan M, Adnan M. Serine arginine protein kinase 1 (SRPK1): A moonlighting protein with theranostic ability in cancer prevention. Mol Biol Rep. 2019; 46(1): 1487-1497.
  13. Han X, Zhang G, Chen G, Wu Y, Xu T, Xu H, et al. Buyang huanwu decoction promotes angiogenesis in myocardial infarction through suppression of PTEN and activation of the PI3K/Akt signalling pathway. J Ethnopharmacol. 2022; 287: 114929.
  14. Yang MH, Ha IJ, Lee SG, Lee J, Um JY, Ahn KS. Ginkgolide C promotes apoptosis and abrogates metastasis of colorectal carcinoma cells by targeting Wnt/β-catenin signaling pathway. IUBMB Life. 2021; 73(10): 1222-1234.
  15. Ren Y, Zhu F, Liu Z. Inhibitory effect of icariin on osteosarcoma cell proliferation via the Wnt/β-catenin signaling pathway. Oncol Lett. 2018; 16(2): 1405-1410.
  16. Rappaport JA, Entezari AA, Caspi A, Caksa S, Jhaveri AV, Stanek TJ, et al. A β-catenin-TCF-sensitive locus control region mediates GUCY2C ligand loss in colorectal cancer. Cell Mol Gastroenterol Hepatol. 2022; 13(4): 1276-1296.
  17. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D’Amico M, Pestell R, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA. 1999; 96(10): 5522-5527.   
  18. Bhatt M, Patel M, Adnan M, Reddy MN. Anti-metastatic effects of lupeol via the inhibition of MAPK/ERK pathway in lung cancer. Anticancer Agents Med Chem. 2021; 21(2): 201-206.
  19. Adnan M, Siddiqui AJ, Hamadou WS, Snoussi M, Badraoui R, Ashraf SA, et al. Deciphering the molecular mechanism responsible for efficiently inhibiting metastasis of human non-small cell lung and colorectal cancer cells targeting the matrix metalloproteinases by Selaginella repanda. Plants (Basel). 2021; 10(5): 979.
  20. Nguyen JQ, Irby RB. TRIM21 is a novel regulator of Par-4 in colon and pancreatic cancer cells. Cancer Biol Ther. 2017; 18(1): 16-25.
  21. Yoon SY, Park SJ, Park YJ. The anticancer properties of cordycepin and their underlying mechanisms. Int J Mol Sci. 2018; 19(10): 3027.
  22. Wang CY, Tsai SW, Chien HH, Chen TY, Sheu SY, So EC, et al. Cordycepin inhibits human gestational choriocarcinoma cell growth by disrupting centrosome homeostasis. Drug Des Devel Ther. 2020; 14: 2987-3000.
  23. Zheng Q, Sun J, Li W, Li S, Zhang K. Cordycepin induces apoptosis in human tongue cancer cells in vitro and has antitumor effects in vivo. Arch Oral Biol. 2020; 118: 104846.
  24. Guo Z, Chen W, Dai G, Huang Y. Cordycepin suppresses the migration and invasion of human liver cancer cells by downregulating the expression of CXCR4. Int J Mol Med. 2020; 45(1): 141-50.
  25. Xu JC, Zhou XP, Wang XA, Xu MD, Chen T, Chen TY, et al. Cordycepin induces apoptosis and G2/M phase arrest through the ERK pathways in esophageal cancer cells. J Cancer. 2019; 10(11): 2415-2424.
  26. Lee SY, Debnath T, Kim SK, Lim BO. Anti-cancer effect and apoptosis induction of cordycepin through DR3 pathway in the human colon cancer cell HT-29. Food Chem Toxicol. 2013; 60: 439-447.
  27. Jeong JW, Park C, Cha HJ, Hong SH, Park SH, Kim GY, et al. Cordycepin inhibits lipopolysaccharide-induced cell migration and invasion in human colorectal carcinoma HCT-116 cells through down-regulation of prostaglandin E2 receptor EP4. BMB Rep. 2018; 51(10): 532-537.
  28. Lee SJ, Moon GS, Jung KH, Kim WJ, Moon S-K. c-Jun N-terminal kinase 1 is required for cordycepin-mediated induction of G2/M cell-cycle arrest via p21WAF1 expression in human colon cancer cells. Food Chem Toxicol. 2010; 48(1): 277-283.
  29. Lin J, Song T, Li C, Mao W. GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer. Biochim Biophys Acta Mol Cell Res. 2020; 1867(5): 118659.
  30. Vijay GV, Zhao N, Den Hollander P, Toneff MJ, Joseph R, Pietila M, et al. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer. Breast Cancer Res. 2019; 21(1): 37.
  31. Yuan L, Zhou M, Huang D, Wasan HS, Zhang K, Sun L, et al. Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial‑ mesenchymal transition via the AKT/ GSK‑3β/Snail signaling pathway. Mol Med Rep. 2019; 20(3): 2783- 2795.
  32. Edderkaoui M, Chheda C, Soufi B, Zayou F, Hu RW, Ramanujan VK, et al. An inhibitor of GSK3B and HDACs kills pancreatic cancer cells and slows pancreatic tumor growth and metastasis in mice. Gastroenterology. 2018; 155(6): 1985-1998.
  33. Yang M, Zhong WW, Srivastava N, Slavin A, Yang J, Hoey T, et al. G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the {beta}-catenin pathway. Proc Natl Acad Sci USA. 2005; 102(17): 6027-6032.
  34. Zhao Y, Li B, Wang G, Ge S, Lan X, Xu G, et al. Dendrobium officinale polysaccharides inhibit 1-Methyl-2-Nitro-1-Nitrosoguanidine induced precancerous lesions of gastric cancer in rats through regulating Wnt/β-Catenin pathway and altering serum endogenous metabolites. Molecules. 2019; 24(14): 2660.
  35. Zheng Q, Yao D, Cai Y, Zhou T. NLRP3 augmented resistance to gemcitabine in triple-negative breast cancer cells via EMT/ IL-1β/Wnt/β-catenin signaling pathway. Biosci Rep. 2020; 40(7): BSR20200730.
  36. Dai J, Wei R, Zhang P, Kong B. Overexpression of microRNA- 195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway. J Transl Med. 2019; 17(1): 190.
  37. Liu Y, Xi Y, Chen G, Wu X, He M. URG4 mediates cell proliferation and cell cycle in osteosarcoma via GSK3β/β-catenin/cyclin D1 signaling pathway. J Orthop Surg Res. 2020; 15(1): 226.
  38. Chen JS, Huang JQ, Luo B, Dong SH, Wang RC, Jiang ZK, et al. PIK3CD induces cell growth and invasion by activating AKT/GSK- 3β/β-catenin signaling in colorectal cancer. Cancer Sci. 2019; 110(3): 997-1011.